Metastasis
149
26
29
50
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
13 trials with published results (9%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.4%
14 terminated out of 149 trials
78.1%
-8.4% vs benchmark
8%
12 trials in Phase 3/4
26%
13 of 50 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 50 completed trials
Clinical Trials (149)
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway
Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis
Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.
A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC
Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients
Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy
Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention
Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.
Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)